-+ 0.00%
-+ 0.00%
-+ 0.00%

Alnylam Pharmaceuticals Price Target Cut to $530.00/Share From $535.00 by Truist Securities

Dow Jones·01/08/2026 16:52:00

登錄查看新聞詳情